Effect of subcutaneous recombinant human erythropoetin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial
- 1 June 1998
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (11) , 1996-2002
- https://doi.org/10.1038/bjc.1998.331
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Serum erythropoietin levels in patients with solid tumoursEuropean Journal Of Cancer, 1994
- Hematopoietic growth factors and the treatment of tumor-associated anemiasAnnals of Hematology, 1994
- Erythropoietin treatment of chronic anaemia of cancerEuropean Journal Of Cancer, 1993
- Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated AnemiaJNCI Journal of the National Cancer Institute, 1992
- A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factorsCancer, 1991
- Decreased Erythropoietin Response in Patients with the Anemia of CancerNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- ErythropoietinTransfusion, 1989
- Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygenThe British Journal of Radiology, 1983
- Role of the Kidney in ErythropoiesisNature, 1957